Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Charles River and SAMDI Tech Partner to Increase Opportunities for Drug Candidate Hit

By SAMDI Tech, Inc. | September 12, 2018

SAMDI Tech, Inc., the industry’s leading provider of label-free drug discovery solutions, has partnered with Charles River Laboratories, which provides products and services that accelerate research and drug development efforts, to expand its small molecule screening collection and maximize its clients’ opportunities to discover hit compounds for their drug discovery projects.

Through the two-year partnership, SAMDI Tech’s clients will be able to use more than 150,000 sourced molecules from Charles River’s premier collection of lead-like compounds in their drug discovery projects. With access to more than one million small molecules in total, SAMDI Tech’s clients can choose to complete their high-throughput projects with any combination of molecules from its vendors or its own libraries.

“Bringing together a diverse set of high-quality compounds and the benefits of SAMDI technology not only speeds up timelines and maximizes the probability of finding early-stage drug candidates for our clients, it takes them one step closer to clinical trials with a new treatment option,” said Emilio Córdova, PhD, MBA, chief executive officer at SAMDI Tech.

SAMDI Tech simplifies and streamlines its clients’ drug candidate selections. Using its proprietary label-free, high-throughput SAMDI assay, SAMDI Tech screens any number of compounds against a client’s target while ensuring industry-leading turnaround times and high-quality data that accelerate discovery efforts.

“We are pleased to partner with SAMDI Tech to combine our experience in compiling high-quality screening libraries with their proprietary screening technology,” said Jackie Macritchie, senior managing director, discovery, at Charles River. “Leveraging SAMDI Tech’s technology and Charles River’s diversity screening library enhances the potential for identifying hit molecules across a wide range of target classes and disease areas.”

(Source: SAMDI Tech)


Filed Under: Drug Discovery and Development

 

Related Articles Read More >

Collage of close-up male and female eyes isolated on colored neon backgorund. Multicolored stripes. Concept of equality, unification of all nations, ages and interests. Diversity and human rights
How a ‘rising tide’ of inclusivity is transforming clinical trials
Mary Marcus appointed CEO of NewAge Industries
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
Data analytics tools help doctors analyze trends in patient outcomes and population health.
External comparator studies: What researchers need to know to minimize bias
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE